Ron A A Mathot (Ron Mathôt, Ron A A Mathôt, Ron A Mathôt)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Pseudomonas Aeruginosa

Machine Learning

Juvenile Idiopathic Arthritis

Top Venues

Clinical pharmacology and therapeutics

CPT: pharmacometrics & systems pharmacology

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander Janssen, Louk Smalbil, Frank C Bennis, Marjon H Cnossen, Ron A A Mathot, null null
A Generative and Causal Pharmacokinetic Model for Factor VIII in Hemophilia A: A Machine Learning Framework for Continuous Model Refinement. Clinical pharmacology and therapeutics 115 (4) (2024)
Alexander Janssen, Louk Smalbil, Frank C Bennis, Marjon H Cnossen, Ron A A Mathot, null null
A Generative and Causal Pharmacokinetic Model for Factor VIII in Hemophilia A: A Machine Learning Framework for Continuous Model Refinement. Clinical pharmacology and therapeutics 115 (4) (2024)
Alexander Janssen, Louk Smalbil, Frank C Bennis, Marjon H Cnossen, Ron A A Mathot, null null
A Generative and Causal Pharmacokinetic Model for Factor VIII in Hemophilia A: A Machine Learning Framework for Continuous Model Refinement. Clinical pharmacology and therapeutics (2024)
Michael E Cloesmeijer, Erik Sjögren, Sjoerd F Koopman, Peter J Lenting, Marjon H Cnossen, Ron A A Mathot, null null
PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space. CPT: pharmacometrics & systems pharmacology (2024)
Alexander Janssen, Louk Smalbil, Frank C Bennis, Marjon H Cnossen, Ron A A Mathot, null null
A Generative and Causal Pharmacokinetic Model for Factor VIII in Hemophilia A: A Machine Learning Framework for Continuous Model Refinement. Clinical pharmacology and therapeutics 115 (4) (2024)
Marjon H Cnossen, Iris van Moort, Simone H Reitsma, Moniek P M de Maat, Roger E G Schutgens, Rolf T Urbanus, Hester Floor Lingsma, Ron A A Mathot, Samantha C Gouw, Karina Meijer, Annelien L Bredenoord, Rieke van der Graaf, Karin C J Fijnvandraat, Alexander Benjamin Meijer, Emile van den Akker, Ruben Bierings, Jeroen C J Eikenboom, Maartje van den Biggelaar, Masja De Haas, Jan Voorberg, Frank W G Leebeek, null null
SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders. Journal of thrombosis and haemostasis : JTH (2022)
Selma Atalay, Sophie E Berends, Hans M M Groenewoud, Ron A A Mathot, Marcellus D Njoo, Johannes M Mommers, Paul M Ossenkoppele, Marjolein I A Koetsier, Maartje A M Berends, Annick de Vries, Peter Cornelis Maria van de Kerkhof, Alfons A den Broeder, Elke M G J de Jong, Juul M P A van den Reek
Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial. The Journal of dermatological treatment 33 (5) (2022)
Tim Preijers, Laura Bukkems, Max van Spengler, Frank Leebeek, Marjon Cnossen, Ron A A Mathot
In silico comparison of pharmacokinetic properties of three extended half-life factor IX concentrates. European journal of clinical pharmacology 77 (8) (2021)
Annabel Werumeus Buning, Caspar J Hodiamont, Natalia M Lechner, Margriet Schokkin, Paul W G Elbers, Nicole P Juffermans, Ron A A Mathot, Menno D de Jong, Reinier M van Hest
Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected Pseudomonas aeruginosa Infection. Antibiotics (Basel, Switzerland) 10 (6) (2021)
Jing 'Daisy' Zhu, Yi Shuan Shirley Wu, Ryan J Beechinor, Ryan M Kemper, Laura H Bukkems, Ron A A Mathot, Marjon H Cnossen, Daniel Gonzalez, Sheh-Li Chen, Nigel S Key, Daniel J Crona
Pharmacokinetics of perioperative FVIII in adult patients with haemophilia A: An external validation and development of an alternative population pharmacokinetic model. Haemophilia : the official journal of the World Federation of Hemophilia 27 (6) (2021)
Mohammed Khurshed, Remco J Molenaar, Myra E van Linde, Ron A A Mathot, Eduard A Struys, J Tom van Wezel, Cornelis J F van Noorden, Heinz-Josef Klümpen, Judith V M G Bovée, Johanna W Wilmink
A Phase Ib Clinical Trial of Metformin and Chloroquine in Patients with IDH1-Mutated Solid Tumors. Cancers 13 (10) (2021)
Charlotte I Stroes, Sandor Schokker, Remco J Molenaar, Ron A A Mathot, Maarten F Bijlsma, Stephanie O van der Woude, João P Belo Pereira, Gerrit K J Hooijer, Rob H A Verhoeven, Annemieke Cats, Cecile Grootscholten, Johanna W van Sandick, Geert-Jan Creemers, Grard A P Nieuwenhuijzen, Nadia Haj Mohammad, Jelle P Ruurda, Sybren L Meijer, Maarten C C M Hulshof, Mark Ivo van Berge Henegouwen, Hanneke W M van Laarhoven
A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX. Cancers 13 (4) (2021)
Tine M H J Goedhart, Laura H Bukkems, C Michel Zwaan, Ron A A Mathot, Marjon H Cnossen, null null
Population pharmacokinetic modeling of factor concentrates in hemophilia: an overview and evaluation of best practice. Blood advances 5 (20) (2021)